首页> 外文期刊>Archives of medical research >Supplementation of n3 Long-chain Polyunsaturated Fatty Acid Synergistically Decreases Insulin Resistance with Weight Loss of Obese Prepubertal and Pubertal Children
【24h】

Supplementation of n3 Long-chain Polyunsaturated Fatty Acid Synergistically Decreases Insulin Resistance with Weight Loss of Obese Prepubertal and Pubertal Children

机译:补充n3长链多不饱和脂肪酸可协同降低肥胖前青春期和青春期儿童的胰岛素抵抗和体重减轻

获取原文
获取原文并翻译 | 示例
           

摘要

Background and Aims: Supplementation with n3 long-chain polyunsaturated fatty acids (n3-LCPUFA) appears to affect body weight, adipokines, and insulin resistance (IR) in obese individuals. However, it is unclear whether the effect on IR is independent of weight loss and if the same effect is observed in children. We undertook this study to analyze the effect of supplementation with n3-LCPUFA on adipokine concentration and IR of prepubertal and pubertal children, independent of weight loss. Methods: Included were 76 children, 9- to 18-years of age. Subjects were overweight and insulin resistant, but otherwise healthy. They were randomly assigned to receive 900 mg n3-LCPUFA daily (Omega III, Salmon Oil, GNLD) or placebo for 1 month. No dietary intervention was conducted. Dietary information, anthropometry, and blood samples to measure adipokines and IR were obtained at baseline. Anthropometry and measurement of biochemical parameters were repeated at the end of follow-up. For analysis, children were stratified by treatment (placebo and n3-FA) and according to changes in body weight (increase, decrease, unchanged). Results: Twenty seven children received placebo and 49 received the n3-LCPUFA. Despite no differences at baseline, only the n3-FA group decreased fasting insulin and HOMA-IR (p <0.010). Significant differences between groups were observed for changes in TNF-α, leptin and adiponectin after supplementation (p <0.050). At the end of the 1-month period, 16 children lost weight and 27 children gained weight. Multiple analysis demonstrated that supplementation with n3-LCPUFA decreased HOMA-IR by 15% after adjusting for puberty, treatment adherence, changes in adipokines, and weight loss. Interaction between supplementation and weight loss was significant (p = 0.007). Conclusions: Supplementation with n3-LCPUFA is a potential beneficial tool for obese at-risk children.
机译:背景与目的:补充n3长链多不饱和脂肪酸(n3-LCPUFA)似乎会影响肥胖个体的体重,脂肪因子和胰岛素抵抗(IR)。然而,目前尚不清楚对IR的影响是否与体重减轻无关,以及在儿童中是否观察到相同的影响。我们进行了这项研究,以分析补充n3-LCPUFA对青春期前和青春期儿童的脂肪因子浓度和IR的影响,而与体重减轻无关。方法:纳入76名9至18岁的儿童。受试者超重且胰岛素抵抗,但其他方面健康。他们被随机分配接受每日900 mg n3-LCPUFA(Omega III,鲑鱼油,GNLD)或安慰剂治疗1个月。没有进行饮食干预。在基线时获得饮食信息,人体测量学和血样以测量脂肪因子和IR。在随访结束时重复人体测量和生化参数的测量。为了进行分析,将儿童根据治疗方法(安慰剂和n3-FA)和体重变化(增加,减少,不变)进行分层。结果:27名儿童接受了安慰剂,49名儿童接受了n3-LCPUFA。尽管基线无差异,但只有n3-FA组降低了空腹胰岛素和HOMA-IR(p <0.010)。补充后,各组间TNF-α,瘦素和脂联素的变化存在显着差异(p <0.050)。在1个月的末期,减肥的儿童有16名,体重增加的儿童有27名。多项分析表明,在调整青春期,治疗依从性,脂肪因子变化和体重减轻后,补充n3-LCPUFA可使HOMA-IR降低15%。补充剂和减肥之间的相互作用很明显(p = 0.007)。结论:补充n3-LCPUFA是肥胖的高危儿童的潜在有益工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号